Dr. Nathanael Gray, A Syros Pharmaceuticals Scientific Founder, Honored With 2013 Meyenburg Cancer Research Award

Published: Dec 16, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WATERTOWN, Mass.--(BUSINESS WIRE)--Nathanael Gray, Ph.D., a scientific founder of Syros Pharmaceuticals and professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Dana-Farber Cancer Institute, was honored as the sole recipient of the prestigious 2013 Meyenburg Cancer Research Award. Gray was recognized for his groundbreaking work in developing first-in-class chemical inhibitors for wild-type and mutant forms of protein kinases, which are used to pharmaceutically validate new potential targets to treat cancer and other diseases.

Help employers find you! Check out all the jobs and post your resume.

Back to news